4 lakh staff will go without pay, 3.8 lakh ‘on leave’ as US shutdown begins

Agencies
December 23, 2018

Washington, Dec 23: The US government was partially shut down early on Saturday in a fierce dispute over President Donald Trump’s demands that Congress assign USD 5 billion for a wall along the border with Mexico.

After failing to strike a budget deal on Friday, congressional leaders and the White Housepledged to keep talking through the weekend in search of a deal to end the shutdown ahead of the Christmas holiday.

The impasse came after Trump threw a wrench into the works earlier in the week by refusing to agree to a short-term funding deal cut by Democratic and Republican senators because it did not include the USD 5 billion for his border wall.

The US House of Representatives, where Republicans have a majority until Democrats take over on January 3, then passed a bill that including the $5 billion, but it ran aground in the Senate and the shutdown began at midnight on Friday.

After it became clear the House bill lacked the votes to pass, Senate leaders huddled with vice president Mike Pence and other White House officials to try to figure out a path forward.

They failed and lawmakers in both houses of Congress were sent home.

Trump tried to blame Democrats.

“We’re going to have a shutdown. There’s nothing we can do about that because we need the Democrats to give us their votes,” he said in a video posted to his Twitter account two hours before the midnight deadline.

Democrats repeatedly reminded Trump, and voters, that he said last week he would be “proud” to shut the government down in order to get wall funding.

“President Trump has thrown a temper tantrum and now has us careening towards a ‘Trump shutdown’ over Christmas,” Senate Democratic leader Chuck Schumer said on the Senate floor on Friday.

About three-quarters of federal government programs are funded through to Sept 30 next year, but the financing for all others - including the departments of Homeland Security, Justice and Agriculture - expired at midnight.

Federal parks will close and more than 400,000 federal “essential” employees in those agencies will work without pay until the dispute is resolved. Another 380,000 will be “furloughed”, meaning they are put on temporary leave.

Law enforcement efforts, border patrols, mail delivery and airport operations will keep running.

Impasse

For the shutdown to end, both the House and the Senate will have to approve any deal negotiated between Trump’s team and Republican and Democratic leaders.

The shutdown could persist at least until a new Congress convenes on January 3, and Democrats take control of the House from Republicans. That does not necessarily mean, however, that Trump would agree to a compromise.

The shutdown comes at the end of a perilous week for the president, one that saw Defense Secretary James Mattis resign in protest after Trump’s sudden decision to pull US troops out of Syria.

The Syria move was widely criticized, even by senior Republicans in Congress. And continued heavy losses in the stock market were in part fueled by the political turmoil.

While Trump made the promise of building a border wall a fixture of his 2016 election campaign, it is not a top-tier priority for most Americans.

According to a Reuters/Ipsos poll in late November, only 31 percent of those surveyed said improved border security should be one of the top three priorities for Congress.

That suggests Trump is taking a political risk by gambling on a shutdown to press his point at a time when Democrats are gearing up for their 2020 presidential primary and looking for issues with which to seize an advantage.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 29,2020

If everything goes as Russia’s expectation, it will be world’s first country to approve a coronavirus vaccine for widespread in the second week of August despite safety and efficacy concerns, according to a report. The adenoviral vector-based vaccine developed by Russian military and government researchers is currently in phase 2 trials.

According to a report from CNN, Russian officials are hoping to get approval for the COVID-19 vaccine developed by the Moscow-based Gamaleya Institute on Agust 10 or even before that. The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first.

“It’s a Sputnik moment,” said Kirill Dmitriev, head of Russia’s sovereign wealth fund, which is financing Russian vaccine research, referring to the successful 1957 launch of the world’s first satellite by the Soviet Union, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” he was quoted as saying.

However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report. The vaccine is in the second phase of testing with developers planning to launch the phase 3 trials sometime after August 3.

Earlier, Interfax reported, citing Health Minister Mikhail Murashko, that the vaccine will be widely used in parallel with phase 3 trials. He said the country plans to vaccinate medics who are at high-risk for COVID-19 next month before clinical trials are completed.

Murashko added that individuals at higher risk of getting infected with the coronavirus such as older people or those with health conditions will also be prioritised for the vaccine, although he did not estimate or reveal when that would happen. The minister added 800 people will be recruited for the phase 3 trials.

Meanwhile, health officials were more cautious considering the fact that human testing of the vaccine is incomplete, and the state registration is expected to begin after August 3, reported The Moscow Times.

On Monday, Moderna and Pfizer announced the commencement of the final phase 3 trials of their candidate vaccines against the SARS-CoV-2 virus, which has so far claimed at least 654,477 lives and infected 16,514,500 people worldwide. 

Researchers will recruit up to 30,000 volunteers in separate trials both backed by the US government. India's first indigenous coronavirus vaccine, COVAXIN, is undergoing phase 1 human clinical trials across the country. More than 150 COVID-19 vaccines are being developed all over the world with at least six candidates already in late-stage clinical trials.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 28,2020

Geneva, Apr 28: The global death toll from the novel coronavirus has increased over the past 24 hours by nearly 5,000 to top 198,000, the World Health Organisation (WHO) said.

According to the latest WHO data, 85,530 new cases of infection have been registered globally over the past day, with 4,982 deaths.

The overall number of COVID-19 cases worldwide increased to 2,878,196 and the death count reached 198,668.

There are 1,359,380 confirmed cases and 124,525 deaths in Europe.

The number of cases in the Americas total 1,140,520, with 58,492 deaths.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 7,2020

Moscow, Aug 7: Russia will register its first vaccine against the coronavirus on August 12, Deputy Health Minister Oleg Gridnev said on Friday.

The vaccine has been developed jointly by the Gamaleya Research Institute and the Russian Defence Ministry.

"The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trials are extremely important. We have to understand that the vaccine must be safe. Medical professionals and senior citizens will be the first to get vaccinated," Gridnev told reporters at the opening of a cancer centre building in the city of Ufa.

According to the minister, the effectiveness of the vaccine will be judged when the population immunity has formed.

Clinical trials of the vaccine began on June 18 and included 38 volunteers. All of the participants developed immunity. 

The first group was discharged on July 15 and the second group on July 20.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.